TrialClinical and translational science2022

Safety, tolerability, and pharmacokinetics of single and multiple topical ophthalmic administration of imatinib mesylate in healthy subjects.

Joo Young Na et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.